Interpace Biosciences, Inc.
IDXGD
$6.98
-$0.02-0.29%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 158.00K | 721.00K | 22.66M | 911.00K | -640.00K |
| Total Depreciation and Amortization | 236.00K | 225.00K | 221.00K | 211.00K | 199.00K |
| Total Amortization of Deferred Charges | -- | -- | 16.00K | 16.00K | 15.00K |
| Total Other Non-Cash Items | 283.00K | 281.00K | -21.23M | 112.00K | 214.00K |
| Change in Net Operating Assets | -579.00K | -944.00K | 471.00K | 688.00K | 732.00K |
| Cash from Operations | 98.00K | 283.00K | 2.14M | 1.94M | 520.00K |
| Capital Expenditure | -57.00K | -141.00K | -38.00K | -117.00K | -201.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -57.00K | -141.00K | -38.00K | -117.00K | -201.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -1.00M | -900.00K | -1.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -18.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -13.00K |
| Cash from Financing | -- | -- | -1.02M | -900.00K | -1.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.00K | 142.00K | 1.08M | 921.00K | -694.00K |